The Royal Institute of Technology (KTH), based in Stockholm, is Sweden’s premier technical university. KTH has previously collaborated with ENGICOIN partner UvA to develop a microfluidic- based screening platform for engineered cyanobacteria, which will be used in the ENGICOIN project to screen lactate-producing mutant strains.
Participation in the ENGICOIN project is through the KTH School of Biotechnology, which is located at the Science for Life Laboratory in Stockholm.
KTH will be active in the development of a photosynthetic cell factory producing lactate.
Paul Hudson’s group at KTH has expertise in metabolic engineering of cyanobacteria, including developing state-of–the-art gene editing tools, genome scale metabolic modelling, and systems-biology analysis of gene expression during stress.
KTH will be the partner responsible for the training activities related to ENGICOIN project.